Chief Executive Officer
Mark Davison is Principal Consultant of Blue Sphere Health (“Bluesphere”) an international healthcare consultancy focusing on traceability and authentication of medicines.
His 27 years of drug industry experience includes GlaxoSmithKline, contract research organisations, biotechnology companies and security vendors. At Bluesphere, Mark works with drug companies, technology suppliers and public sector organisations on serialisation and brand protection for various markets. Projects include preparing for FMD (EU) and DSCSA (USA) compliance and identifying added-value commercial opportunities around traceable supply chains. Mark is a frequent speaker at industry conferences and is the author of “Pharmaceutical Anti-Counterfeiting” (476pp, Wiley, N.Y., 2011). www.bluespherehealth.com